Extract

In this study several dose levels of ASP3652, given orally for 12 weeks, will be compared with placebo in the treatment of female patients with Bladder Pain Syndrome / Interstitial Cystitis.

Inclusion criteria

• Cystitis, Interstitial ,Urologic Diseases ,Urinary Bladder Disease ,pain

Country

• Belgium
• Czech Republic
• Denmark
• Germany
• Latvia
• Lithuania
• Netherlands
• Poland
• Portugal
• Romania
• Russian Federation
• Spain

Links

• ictrp
• nct